SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Jagsonpal Pharmaceuticals Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
507789 INE048B01035 37.768362 JAGSNPHARM 1.4 1,184.56 27.81 6.36 2
Quarters :
ParticularsDec 2025(Rs.Cr)Sep 2025(Rs.Cr)Jun 2025(Rs.Cr)
Gross Sales72.9574.4775.61
Other Operating Income0.000.000.00
Other Income 2.983.032.83
Total Income75.9277.4978.44
Total Expenditure 58.7658.0361.40
PBIDT17.1619.4617.04
Interest 0.260.270.25
PBDT16.9119.2016.78
Depreciation2.392.392.35
Tax3.753.813.17
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.180.430.47
Reported Profit After Tax10.9512.5710.80
Extra-ordinary Items -1.540.000.00
Adjusted Profit After Extra-ordinary item12.4912.5710.80
    
EPS (Unit Curr.)1.671.881.60
EPS (Adj) (Unit Curr.)1.671.881.60
Calculated EPS (Unit Curr.)1.641.891.62
Calculated EPS (Adj) (Unit Curr.)1.641.891.62
Calculated EPS (Ann.) (Unit Curr.)6.567.556.49
Calculated EPS (Adj) (Ann.) (Unit Curr.)6.567.556.49
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity13.3613.3313.31
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)23.5226.1322.54
PBDTM(%)23.1825.7822.19
PATM(%)15.0116.8814.28